Salbutamol exhibits androgenic activity in vitro
article
OA: bronze
CC0
AI-generated summary
This study investigated salbutamol's mechanism of anabolic action in vitro, finding it exhibits androgenic activity through androgen receptor agonistic activity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Salbutamol has been shown to mediate anabolic effects after intravenous administration. However, the mechanism responsible for the anabolic actions of salbutamol remains unknown. AIM: To investigate the potential mechanism by which salbutamol mediates anabolic effects in vitro. METHODS: The potential androgenic activity of salbutamol was investigated in vitro by the A-Screen assay that measures androgen-dependent inhibition of proliferation of the androgen receptor (AR)-positive human mammary carcinoma cell line, MCF7-AR1. RESULTS: The assay was validated with three known androgens; methyltrienolone (R1881), 5alpha-dihydrotestosterone (DHT) and danazol. IC50 values of R1881, DHT and danazol, 4.41x10(-11), 4.44x10(-11) and 1.08x10(-8) M, respectively, were in the ranges known from earlier studies. Our results demonstrate that salbutamol exhibits androgenic activity, with an IC50 value of 8.93x10(-6) M. Anti-estrogenic or cytotoxic effects, which might have interfered with the assay, were excluded by additional experiments on wild-type MCF7 and MCF7-AR1 cells, respectively. CONCLUSION: These data indicate that salbutamol exerts anabolic effects through androgen receptor agonistic activity in vitro.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (32)
- doi:10.1210/en.140.1.318 via openalex
- doi:10.1136/bjsm.2006.027748 via openalex
- doi:10.2165/00007256-199724060-00003 via openalex
- doi:10.1210/endo.140.1.6435 via openalex
- doi:10.1016/s0022-1759(97)00137-3 via openalex
- doi:10.1079/bjn19860104 via openalex
- doi:10.1016/0140-6736(92)93198-v via openalex
- doi:10.1042/cs0830615 via openalex
- doi:10.1016/0742-8413(88)90234-4 via openalex
- doi:10.1016/0140-6736(92)92591-3 via openalex
- doi:10.1210/endo.138.4.5047 via openalex
- doi:10.1042/bj2610001 via openalex
- doi:10.2165/00007256-200232090-00004 via openalex
- doi:10.1016/0026-0495(94)90054-x via openalex
- doi:10.1249/00005768-199511000-00002 via openalex
- doi:10.1073/pnas.83.8.2496 via openalex
- doi:10.1289/ehp.112-1241964 via openalex
- doi:10.1007/bf01122727 via openalex
- doi:10.1055/s-2004-821224 via openalex
- doi:10.1289/ehp.95103s4113 via openalex
- doi:10.1055/s-2004-821223 via openalex
- doi:10.1016/0140-6736(92)93110-9 via openalex
- doi:10.1016/0140-6736(93)92674-i via openalex
- doi:10.1289/ehp.95103s7113 via openalex
- doi:10.1152/ajpendo.1992.263.1.e50 via openalex
- W6680896281 via openalex
- doi:10.1002/jps.20218 via openalex
- doi:10.1289/ehp.6715 via openalex
- doi:10.1093/jnci/82.13.1107 via openalex
- doi:10.1210/en.138.4.1406 via openalex
- doi:10.1136/bjsm.2006.026237 via openalex
- doi:10.1042/bj2640573 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:15:24.675520+00:00
License: CC0
· commercial use OK